These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9663175)

  • 1. Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations.
    Kovacs SJ; Martin DE; Everitt DE; Patterson SD; Jorkasky DK
    Clin Pharmacol Ther; 1998 Jun; 63(6):617-22. PubMed ID: 9663175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol.
    Koup JR; Anderson GD; Loi CM
    J Clin Pharmacol; 1998 Sep; 38(9):815-8. PubMed ID: 9753209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I.
    Keung A; Reith K; Eller MG; McKenzie KA; Cheng L; Weir SJ
    Int J Tuberc Lung Dis; 1999 May; 3(5):426-36. PubMed ID: 10331733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
    Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
    Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE; Peng B; Hubert M; Krebs-Brown A; Capdeville R; Keller U; Seiberling M
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.
    Horsmans Y; Desager JP; Harvengt C
    Pharmacol Toxicol; 1992 Oct; 71(4):258-61. PubMed ID: 1454750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in urinary excretion of 6beta-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction.
    Totsuka S; Watanabe T; Koyanagi F; Tanaka K; Yasuda M; Manabe S
    Arch Toxicol; 1999; 73(4-5):203-7. PubMed ID: 10463384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate.
    Borin MT; Chambers JH; Carel BJ; Gagnon S; Freimuth WW
    Clin Pharmacol Ther; 1997 May; 61(5):544-53. PubMed ID: 9164416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEET (N,N-diethyl-m-toluamide) alone and in combination with permethrin increased urinary excretion of 6beta-hydroxycortisol in rats, a marker of hepatic CYP3A induction.
    Abu-Qare AW; Abou-Donia MB
    J Toxicol Environ Health A; 2001 Nov; 64(5):373-84. PubMed ID: 11700004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis.
    Dilger K; Denk A; Heeg MH; Beuers U
    Hepatology; 2005 Mar; 41(3):595-602. PubMed ID: 15726657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of amiodarone on urinary excretion of 6beta-hydroxycortisol in humans.
    Micuda S; Hodac M; Sispera L; Parízek P; Pleskot M; Zimova G; Cerman J; Martínková J; Pidrman V
    Physiol Res; 2001; 50(2):191-6. PubMed ID: 11522047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment.
    Rost KL; Mansmann U; Roots I
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):14-8. PubMed ID: 9021436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of human hepatocyte cultures to study the induction of cytochrome P-450.
    Kostrubsky VE; Ramachandran V; Venkataramanan R; Dorko K; Esplen JE; Zhang S; Sinclair JF; Wrighton SA; Strom SC
    Drug Metab Dispos; 1999 Aug; 27(8):887-94. PubMed ID: 10421615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morning spot and 24-hour urinary 6 beta-hydroxycortisol to cortisol ratios: intraindividual variability and correlation under basal conditions and conditions of CYP 3A4 induction.
    Tran JQ; Kovacs SJ; McIntosh TS; Davis HM; Martin DE
    J Clin Pharmacol; 1999 May; 39(5):487-94. PubMed ID: 10234596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of grapefruit juice on urinary 6 beta-hydroxycortisol/cortisol excretion.
    Seidegård J; Dahlström K; Kullberg A
    Clin Exp Pharmacol Physiol; 1998 May; 25(5):379-81. PubMed ID: 9612666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
    Matheny CJ; Ali RY; Yang X; Pollack GM
    Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes.
    Ramachandran V; Kostrubsky VE; Komoroski BJ; Zhang S; Dorko K; Esplen JE; Strom SC; Venkataramanan R
    Drug Metab Dispos; 1999 Oct; 27(10):1194-9. PubMed ID: 10497147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.